AXIM
Price:
$0.0023
Market Cap:
$694.51K
AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and oncology. The company is developing rapid diagnostic tests, which measure the levels of functional neutralizing antibodies that prevent SARS-CoV-2 from attaching to human cells; serological diagnostic test, which detect neutralizing antibodies that measure adaptive immune response to the SARS-CoV-2 virus; and tests for management of COVID-19 Patients to detect biomarkers related to inflammation. It is also developing rapid quantitative tear tests for Matrix metalloproteinase-9, an inflammatory biomarker for dry eye disease; SBI-183, an anti-metastatic compound suppressing...[Read more]
Industry
Biotechnology
IPO Date
2014-09-02
Stock Exchange
PNK
Ticker
AXIM
According to AXIM Biotechnologies, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.10M. This represents a change of -30.14% compared to the average of 10.16M of the last 4 quarters.
The mean historical Enterprise Value of AXIM Biotechnologies, Inc. over the last ten years is 141.64M. The current 7.10M Enterprise Value has changed 401.04% with respect to the historical average. Over the past ten years (40 quarters), AXIM's Enterprise Value was at its highest in in the March 2017 quarter at 707.27M. The Enterprise Value was at its lowest in in the March 2024 quarter at 9.28M.
Average
141.64M
Median
50.33M
Minimum
9.83M
Maximum
497.33M
Discovering the peaks and valleys of AXIM Biotechnologies, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.83%
Maximum Annual Enterprise Value = 497.33M
Minimum Annual Increase = -96.24%
Minimum Annual Enterprise Value = 9.83M
Year | Enterprise Value | Change |
---|---|---|
2023 | 9.83M | -3.66% |
2022 | 10.20M | -83.87% |
2021 | 63.22M | 17.89% |
2020 | 53.63M | 90.16% |
2019 | 28.20M | -40.03% |
2018 | 47.02M | -90.54% |
2017 | 497.33M | 36.58% |
2016 | 364.13M | 2.83% |
2015 | 12.43M | -96.24% |
2014 | 330.39M | 0.10% |
The current Enterprise Value of AXIM Biotechnologies, Inc. (AXIM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
27.75M
5-year avg
33.02M
10-year avg
141.64M
AXIM Biotechnologies, Inc.’s Enterprise Value is less than Cellectis S.A. (115.55M), less than Biotron Limited (16.98M), greater than Regenicin, Inc. (15.35K), greater than Bioasis Technologies Inc. (397.14K), less than Adynxx, Inc. (0), greater than Ascletis Pharma Inc. (581.00), less than Wesana Health Holdings Inc. (916.46M), greater than BioVaxys Technology Corp. (255.22K), less than GH Research PLC (17.41M), less than Algernon Pharmaceuticals Inc. (392.97M), greater than Mindset Pharma Inc. (1.14M), less than Biostage, Inc. (67.66M), less than BioCardia, Inc. (57.66M), greater than AVAX Technologies, Inc. (6.48M), greater than null (-5896313.00),
Company | Enterprise Value | Market cap |
---|---|---|
115.55M | $183.12M | |
16.98M | $11.30M | |
15.35K | $15.35K | |
397.14K | $284.08K | |
0 | $581.00 | |
581.00 | $172.62M | |
916.46M | $68.30K | |
255.22K | $12.75M | |
17.41M | $482.30M | |
392.97M | $1.25M | |
1.14M | $54.51M | |
67.66M | $57.82M | |
57.66M | $10.12K | |
6.48M | $6.89K | |
-5896313.00 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AXIM Biotechnologies, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AXIM Biotechnologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is AXIM Biotechnologies, Inc.'s Enterprise Value?
What is the highest Enterprise Value for AXIM Biotechnologies, Inc. (AXIM)?
What is the 3-year average Enterprise Value for AXIM Biotechnologies, Inc. (AXIM)?
What is the 5-year average Enterprise Value for AXIM Biotechnologies, Inc. (AXIM)?
How does the current Enterprise Value for AXIM Biotechnologies, Inc. (AXIM) compare to its historical average?